RNST Shorts Hold Ground as Analysts Mark Down Targets

Renasant Corporation fell 3.9% over the past week, worse than the median decline of 1.1% for its closest regional bank peers. Short interest has climbed to 6.1% of free float, the highest in at least a year, and two analyst firms have now trimmed their price targets following Q3 results.

Analyst Marks Keep Coming Down

Raymond James cut its rating on October 29 from Strong Buy to Outperform, dropping the price target to $45 from $50. That followed TD Cowen's own reduction the same day, from $46 to $45, while holding its Buy rating. Both moves came in the session after earnings, when the stock fell 3.7%.

The consensus mean target now sits at $46.86, still well above the October 30 close of $39.93. But the directional drift from both firms is clear. TD Cowen has cut three times since October 2025. Raymond James moved from its highest rating to a step below it. Neither firm has turned negative; both have been walking estimates lower.

The FDIC call-report data ORTEX tracks for Renasant's bank charters shows quarterly net income rose for four consecutive quarters through Q2 2026. That streak has not stopped analysts from trimming their views post-earnings.

Shorts Build on Their Own Terms

Short interest rose 12.6% over the past week and 33% over the past month. The accumulation is deliberate. Availability stands at 1,238% of outstanding short interest, meaning shares to borrow are plentiful. The cost to borrow is 0.42%, down about 11% on the week. There is no lending-market pressure forcing these positions closed.

The ORTEX short score has ticked to 52.3 from 49.4 ten days ago. The move is gradual but consistent with the pace of new positioning.

Peer performance provides context. UBSI and FULT each fell less than 1% over the past week. TRMK dropped 4.5%, closer to Renasant's pace. The sector had a rough week, but RNST underperformed most of its closest correlates.

Options Signal Has Faded

The put/call ratio of 0.036 remains near the low end of its 52-week range of 0.002 to 0.846. Before Q3 earnings the extreme call skew read as pre-event positioning. Now that earnings have passed and the stock has sold off, the same options structure is harder to interpret as a conviction statement.

The ORTEX short score factor rank sits in the 11th percentile, and the days-to-cover figure from the most recent FINRA fortnightly data is 8.2 days, one of the higher readings among comparable regional banks.

---

What to watch: The next earnings date is 26 January 2027. Any further analyst target reductions between now and then, particularly from Piper Sandler (currently at $48) or a fresh move from TD Cowen, would narrow the gap between consensus and the current price to a level that could attract additional short interest.